Wells Fargo & Company Kronos Bio, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.02 - $1.3 $6 - $7	6 Added 1.76%	347 $0
Q4 2023 Feb 09, 2024	BUY	$0.75 - $1.49 $13 - $26	18 Added 5.57%	341 $0
Q3 2023 Nov 13, 2023	SELL	$1.23 - $2.25 $6,146 - $11,243	-4,997 Reduced 93.93%	323 $0
Q2 2023 Aug 15, 2023	SELL	$1.24 - $1.92 $8,599 - $13,315	-6,935 Reduced 56.59%	5,320 $9,000
Q1 2023 May 12, 2023	BUY	$1.34 - $2.62 $16,421 - $32,108	12,255 New	12,255 $17,000
Q3 2022 Nov 14, 2022	SELL	$3.35 - $5.55 $1,329 - $2,203	-397 Reduced 76.2%	124 $0
Q2 2022 Aug 12, 2022	SELL	$3.12 - $7.52 $8,480 - $20,439	-2,718 Reduced 83.91%	521 $2,000
Q1 2022 May 16, 2022	SELL	$6.26 - $14.42 $83,852 - $193,155	-13,395 Reduced 80.53%	3,239 $24,000
Q4 2021 Feb 14, 2022	BUY	$11.35 - $21.18 $138,992 - $259,370	12,246 Added 279.08%	16,634 $226,000
Q3 2021 Nov 15, 2021	BUY	$18.17 - $24.7 $77,567 - $105,444	4,269 Added 3587.39%	4,388 $92,000
Q2 2021 Aug 16, 2021	SELL	$20.08 - $29.02 $90,821 - $131,257	-4,523 Reduced 97.44%	119 $3,000
Q1 2021 May 13, 2021	SELL	$27.0 - $32.48 $79,245 - $95,328	-2,935 Reduced 38.74%	4,642 $136,000
Q4 2020 Feb 09, 2021	BUY	$26.68 - $38.23 $202,154 - $289,668	7,577 New	7,577 $226,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $48.8M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.